Susan Bobulsky's most recent trade in Adaptive Biotechnologies Corp was a trade of 62,500 Common Stock done . Disclosure was reported to the exchange on March 4, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Adaptive biotech Corp | Susan Bobulsky | Chief Commercial Officer, MRD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2026 | 62,500 | 469,113 (0%) | 0% | 0 | Common Stock | |
| Adaptive biotech Corp | Susan Bobulsky | Chief Commercial Officer, MRD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2026 | 59,375 | 406,613 (0%) | 0% | 0 | Common Stock | |
| Adaptive biotech Corp | Susan Bobulsky | Chief Commercial Officer, MRD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 180,029 | 180,029 | - | - | Stock Option (right to buy) | |
| Adaptive biotech Corp | Susan Bobulsky | Chief Commercial Officer, MRD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 119,971 | 373,261 (0%) | 0% | 0 | Common Stock | |
| Adaptive biotech Corp | Susan Bobulsky | Chief Commercial Officer, MRD | Sale of securities on an exchange or to another person at price $ 6.98 per share. | 04 Mar 2025 | 26,023 | 347,238 (0%) | 0% | 7.0 | 181,641 | Common Stock |
| Adaptive biotech Corp | Susan Bobulsky | Chief Commercial Officer, MRD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Oct 2024 | 5,000 | 0 | - | - | Stock Option (right to buy) | |
| Adaptive biotech Corp | Susan Bobulsky | Chief Commercial Officer, MRD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.98 per share. | 08 Oct 2024 | 5,000 | 253,290 (0%) | 0% | 2.0 | 9,900 | Common Stock |
| Adaptive biotech Corp | Susan Bobulsky | Chief Commercial Officer, MRD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 199,549 | 199,549 | - | - | Stock Option (right to buy) | |
| Adaptive biotech Corp | Susan Bobulsky | Chief Commercial Officer, MRD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 132,979 | 261,281 (0%) | 0% | 0 | Common Stock | |
| Adaptive biotech Corp | Susan Bobulsky | Chief Commercial Officer, MRD | Sale of securities on an exchange or to another person at price $ 3.44 per share. | 04 Mar 2024 | 6,975 | 248,290 (0%) | 0% | 3.4 | 23,994 | Common Stock |
| Adaptive biotech Corp | Susan Bobulsky | Chief Commercial Officer, MRD | Sale of securities on an exchange or to another person at price $ 3.43 per share. | 04 Mar 2024 | 6,016 | 255,265 (0%) | 0% | 3.4 | 20,635 | Common Stock |